Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05857137 · ClinicalTrials.gov registry record · NA

Psychosis TMS Study

A NA study of Psychosis, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05857137 is a NA study of Psychosis that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05857137, a NA study of Psychosis, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The main goal of this study is to investigate the neural mechanisms of working memory function in patients with early psychosis using Transcranial Magnetic Stimulation (TMS) in conjunction with functional MRI. TMS is a noninvasive method used to modulate brain activity via changing magnetic fields applied over the surface of the scalp.

Conditions Studied

Interventions

  • DEVICE Active TMS
  • DEVICE Placebo TMS

Study Locations (1)

Massachusetts

  • Martinos Center for Biomedical Imaging - Charlestown

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-04-04
Est. Completion 2026-07-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05857137

The ClinicalTrials.gov registry entry for NCT05857137 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (89% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Active TMS is the first listed.

NCT05857137 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05857137 about?

NCT05857137 is a clinical study titled "Psychosis TMS Study". The main goal of this study is to investigate the neural mechanisms of working memory function in patients with early psychosis using Transcranial Magnetic Stimulation (TMS) in conjunction with functional MRI. TMS is a noninvasive method used to modulate brain activity via changing magnetic fields a...

What is the current status of trial NCT05857137?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-04-04. Estimated completion is 2026-07-30.

What conditions does trial NCT05857137 study?

This clinical trial studies the following conditions: Psychosis.

What interventions are being tested in trial NCT05857137?

The interventions under investigation include: Active TMS (DEVICE), Placebo TMS (DEVICE).

Who is sponsoring clinical trial NCT05857137?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05857137 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.